Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01799031 · ClinicalTrials.gov registry record · NA
Educational Intervention for Reducing Work Disability in Breast Cancer Survivors
A NA study of Breast Cancer and Cancer Survivor, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT01799031: Completed NA study of Breast Cancer and Cancer Survivor, sponsored by University of Wisconsin, Madison.
NCT01799031 is a NA study of Breast Cancer and Cancer Survivor that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 44 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01799031, a NA study of Breast Cancer and Cancer Survivor, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies an educational intervention for reducing work disability in breast cancer survivors. Web sites providing symptom management education may be an effective method to help breast cancer survivors reduce work disability after treatment
Primary Outcome
The primary analysis of the effect of the WISE intervention on work ability will be performed using a Wilcoxon rank sum test.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER educational intervention
- PROCEDURE management of therapy complications
- OTHER internet-based intervention
Study Locations (1)
Wisconsin
- University of Wisconsin Hospital and Clinics - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT01799031 record still lists
NCT01799031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01799031 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT01799031 about?
NCT01799031 is a clinical study titled "Educational Intervention for Reducing Work Disability in Breast Cancer Survivors". This randomized clinical trial studies an educational intervention for reducing work disability in breast cancer survivors. Web sites providing symptom management education may be an effective method to help breast cancer survivors reduce work disability after treatment
What is the current status of trial NCT01799031?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2015-07. Estimated completion is 2017-06.
What conditions does trial NCT01799031 study?
This clinical trial studies the following conditions: Breast Cancer, Cancer Survivor.
What interventions are being tested in trial NCT01799031?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), educational intervention (OTHER), management of therapy complications (PROCEDURE), internet-based intervention (OTHER).
Who is sponsoring clinical trial NCT01799031?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01799031 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01799031's enrollment target sits among peer trials
44 852nd of 1224 higher than 371 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia